West Pharmaceutical Services: Low Debt, High Profit, And A Waning Destocking Problem
I grant West Pharmaceutical Services (NYSE: WST ) a buy rating. Some readers might think that the cuts that the U.S. government has made to the country's public healthcare system will undermine the company's revenues. However, my estimationsDaniel Mellado is an economist from Carabobo University with a Master's Degree in Statistics from Simon Bolivar University, both obtained in Venezuela.Daniel worked analyzing the agricultural commodity market and the financial investment portfolio for an agribusiness gro ...